title: Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.
abstract: Radezolid is a novel biaryloxazolidinone in clinical development which shows improved activity, including against linezolid-resistant strains. In a companion paper (29), we showed that radezolid accumulates about 11-fold in phagocytic cells, with approximately 60% of the drug localized in the cytosol and approximately 40% in the lysosomes of the cells. The present study examines its activity against (i) bacteria infecting human THP-1 macrophages and located in different subcellular compartments (Listeria monocytogenes, cytosol; Legionella pneumophila, vacuoles; Staphylococcus aureus and Staphylococcus epidermidis, mainly phagolysosomal), (ii) strains of S. aureus with clinically relevant mechanisms of resistance, and (iii) isogenic linezolid-susceptible and -resistant S. aureus strains infecting a series of phagocytic and nonphagocytic cells. Radezolid accumulated to similar levels ( approximately 10-fold) in all cell types (human keratinocytes, endothelial cells, bronchial epithelial cells, osteoblasts, macrophages, and rat embryo fibroblasts). At equivalent weight concentrations, radezolid proved consistently 10-fold more potent than linezolid in all these models, irrespective of the bacterial species and resistance phenotype or of the cell type infected. This results from its higher intrinsic activity and higher cellular accumulation. Time kill curves showed that radezolid's activity was more rapid than that of linezolid both in broth and in infected macrophages. These data suggest the potential interest of radezolid for recurrent or persistent infections where intracellular foci play a determinant role.
authors.affiliation: Unité de Pharmacologie Cellulaire et Moléculaire and Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
authors.forename: Sandrine
authors.initials: S
authors.lastname: Lemaire
authors.forename: Klaudia
authors.initials: K
authors.lastname: Kosowska-Shick
authors.forename: Peter C
authors.initials: PC
authors.lastname: Appelbaum
authors.forename: Gunther
authors.initials: G
authors.lastname: Verween
authors.forename: Paul M
authors.initials: PM
authors.lastname: Tulkens
authors.forename: Françoise
authors.initials: F
authors.lastname: Van Bambeke
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial; D006801:Humans; D016952:Legionella pneumophila / Q000187:drug effects*; D000069349:Linezolid; D008089:Listeria monocytogenes / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000008:administration & dosage / Q000494:pharmacology*; D010586:Phagocytes / Q000187:drug effects* / Q000382:microbiology*; D051381:Rats; D013211:Staphylococcus aureus / Q000187:drug effects*; D013212:Staphylococcus epidermidis / Q000187:drug effects*
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; C552047:radezolid; D000069349:Linezolid
references.citation: Microb Pathog. 2003 Oct;35(4):159-68
references.pmid: 12946328
references.citation: Trends Microbiol. 2009 Feb;17(2):59-65
references.pmid: 19208480
references.citation: Nat Rev Microbiol. 2009 May;7(5):355-66
references.pmid: 19369951
references.citation: Nat Rev Microbiol. 2009 Jan;7(1):13-24
references.pmid: 19011659
references.citation: J Infect Dis. 2000 Apr;181(4):1337-49
references.pmid: 10762565
references.citation: Antimicrob Agents Chemother. 2009 Sep;53(9):3734-43
references.pmid: 19564365
references.citation: J Med Microbiol. 2007 Oct;56(Pt 10):1290-1295
references.pmid: 17893163
references.citation: Microbes Infect. 2007 Aug;9(10):1167-75
references.pmid: 17761447
references.citation: J Antimicrob Chemother. 2007 Feb;59(2):246-53
references.pmid: 17220162
references.citation: Thromb Haemost. 2005 Aug;94(2):266-77
references.pmid: 16113815
references.citation: J Cell Biol. 1974 Nov;63(2 Pt 1):383-401
references.pmid: 4371790
references.citation: Cell Microbiol. 2006 Nov;8(11):1720-9
references.pmid: 16939532
references.citation: Clin Microbiol Infect. 2008 Aug;14(8):766-77
references.pmid: 18727801
references.citation: Trends Microbiol. 2000 Aug;8(8):341-3
references.pmid: 10920387
references.citation: J Infect Dis. 2009 Nov 1;200(9):1367-70
references.pmid: 19817587
references.citation: Microbes Infect. 2004 Jan;6(1):129-39
references.pmid: 14738901
references.citation: Eur Respir J. 1998 May;11(5):1043-52
references.pmid: 9648953
references.citation: Int J Tissue React. 1994;16(5-6):211-20
references.pmid: 7558665
references.citation: Curr Opin Drug Discov Devel. 2006 Mar;9(2):218-30
references.pmid: 16566292
references.citation: Nat Rev Microbiol. 2009 Sep;7(9):623-8
references.pmid: 19648949
references.citation: Int J Cancer. 1980 Aug;26(2):171-6
references.pmid: 6970727
references.citation: Antimicrob Agents Chemother. 1990 Jun;34(6):1056-60
references.pmid: 2168141
references.citation: Antimicrob Agents Chemother. 2010 Jun;54(6):2540-8
references.pmid: 20385873
references.citation: Infect Immun. 2000 Sep;68(9):5385-92
references.pmid: 10948168
references.citation: J Cell Biol. 2002 Aug 5;158(3):409-14
references.pmid: 12163465
references.citation: Microb Pathog. 1999 Jun;26(6):317-23
references.pmid: 10343060
references.citation: Antimicrob Agents Chemother. 2006 Mar;50(3):841-51
references.pmid: 16495241
references.citation: Antimicrob Agents Chemother. 1987 Mar;31(3):410-6
references.pmid: 3579258
references.citation: J Antimicrob Chemother. 2009 Nov;64(5):1035-43
references.pmid: 19759040
references.citation: Med Microbiol Immunol. 2001 Sep;189(4):217-23
references.pmid: 11599792
references.citation: Cell. 1975 Nov;6(3):331-43
references.pmid: 1052771
references.citation: FEMS Immunol Med Microbiol. 2008 Oct;54(1):53-9
references.pmid: 18625014
references.citation: J Med Microbiol. 2007 Jan;56(Pt 1):83-93
references.pmid: 17172522
references.citation: Antimicrob Agents Chemother. 2008 Oct;52(10):3550-7
references.pmid: 18663023
references.citation: Antimicrob Agents Chemother. 2009 Jun;53(6):2289-97
references.pmid: 19289525
references.citation: Antimicrob Agents Chemother. 2008 Aug;52(8):2797-805
references.pmid: 18519727
references.citation: J Infect Dis. 2004 Jun 1;189(11):2101-9
references.pmid: 15143479
references.citation: Trends Microbiol. 2003 Feb;11(2):80-6
references.pmid: 12598130
references.citation: Proteomics. 2009 Dec;9(24):5484-96
references.pmid: 19834917
references.citation: Biochem Pharmacol. 1978 Feb 15;27(4):415-24
references.pmid: 24449
references.citation: Infect Immun. 2009 Sep;77(9):3611-25
references.pmid: 19564384
references.citation: Antimicrob Agents Chemother. 2006 Feb;50(2):765-9
references.pmid: 16436741
references.citation: Bioorg Med Chem Lett. 2008 Dec 1;18(23):6179-83
references.pmid: 18951792
references.citation: J Clin Microbiol. 1981 Dec;14(6):623-7
references.pmid: 7037831
references.citation: J Antimicrob Chemother. 2003 Apr;51(4):1051-2
references.pmid: 12654747
references.citation: Antimicrob Agents Chemother. 2003 Jul;47(7):2283-92
references.pmid: 12821480
references.citation: Antimicrob Agents Chemother. 2004 Aug;48(8):2853-60
references.pmid: 15273091
references.citation: J Infect Dis. 2005 Sep 15;192(6):1023-8
references.pmid: 16107955
references.citation: Cell Microbiol. 2003 Jun;5(6):417-26
references.pmid: 12780779
references.citation: J Antimicrob Chemother. 2005 Jun;55(6):897-904
references.pmid: 15860552
references.citation: Antimicrob Agents Chemother. 2008 May;52(5):1653-62
references.pmid: 18316525
references.citation: Antimicrob Agents Chemother. 2009 May;53(5):1874-83
references.pmid: 19223616
references.citation: PLoS One. 2008 Jan 09;3(1):e1409
references.pmid: 18183290
references.citation: Nat Rev Microbiol. 2005 Dec;3(12):948-58
references.pmid: 16322743
references.citation: Infect Dis Clin North Am. 2003 Sep;17(3):615-34
references.pmid: 14711080
references.citation: Microbes Infect. 2007 Aug;9(10):1188-95
references.pmid: 17719818
references.citation: J Bone Joint Surg Am. 2005 Jun;87(6):1343-7
references.pmid: 15930546
references.citation: Br J Dermatol. 2002 Jun;146(6):943-51
references.pmid: 12072060